Table 3. Absorption and distribution properties of ISL-1 to ISL-18 and ISL.
Comp. | Absorption | Distribution | ||||
---|---|---|---|---|---|---|
Human intestinal absorption (HIA %) | CaCo-2 cell permeability (nm/s) | MDCK cell permeability (nm/s) | Skin permeability (log kp, cm/h) | Plasma protein binding (%) | Blood–brain barrier penetration (c.brain/c.blood) | |
ISL | 88.30 | 20.15 | 21.54 | –3.28 | 98.25 | 1.13 |
ISL-1 | 95.82 | 29.44 | 163.15 | −2.37 | 97.32 | 1.52 |
ISL-2 | 95.92 | 31.59 | 135.64 | −2.29 | 97.84 | 3.39 |
ISL-3 | 95.82 | 28.15 | 56.86 | −2.60 | 98.29 | 1.94 |
ISL-4 | 96.56 | 28.42 | 0.78 | −2.34 | 100.00 | 3.54 |
ISL-5 | 93.43 | 19.65 | 16.63 | −2.97 | 96.44 | 0.41 |
ISL-6 | 95.82 | 30.28 | 13.62 | −2.60 | 98.08 | 2.63 |
ISL-7 | 93.43 | 19.84 | 27.84 | −2.98 | 97.28 | 0.32 |
ISL-8 | 95.92 | 31.55 | 72.27 | −2.27 | 98.20 | 2.80 |
ISL-9 | 95.93 | 24.94 | 0.10 | −1.51 | 93.50 | 5.13 |
ISL-10 | 95.79 | 20.66 | 51.70 | −2.64 | 92.61 | 0.09 |
ISL-11 | 95.42 | 33.76 | 32.53 | −2.60 | 93.71 | 0.74 |
ISL-12 | 95.83 | 42.02 | 22.39 | −2.64 | 91.98 | 1.92 |
ISL-13 | 96.65 | 30.05 | 60.54 | −2.43 | 100.00 | 6.39 |
ISL-14 | 92.56 | 16.28 | 3.22 | −2.90 | 98.80 | 1.77 |
ISL-15 | 94.83 | 16.99 | 0.09 | −2.90 | 91.68 | 1.62 |
ISL-16 | 95.98 | 39.81 | 0.10 | −2.89 | 90.21 | 0.06 |
ISL-17 | 95.98 | 39.03 | 0.05 | −2.92 | 90.88 | 0.07 |
ISL-18 | 96.66 | 31.47 | 47.11 | −2.31 | 99.41 | 3.21 |
Results were predicted using the server https://preadmet.bmdrc.kr/adme.